Cost of inpatient admissions for immune-related adverse effects from immune checkpoint inhibitor therapy: A single center experience

Authors :: Alexandra C Villani
Molly Thomas
Amanda C. Guidon
Justine V. Cohen
Jacqueline N. Chu
Rebecca Karp Leaf
Alexander T. Faje
Mazen Nasrallah
Kerry L. Reynolds
Ryan J. Sullivan
Jin G. Choi
Steven T. Chen
Ian M. Allen
Sassan Ostvar
Meghan E. Sise
Aditya Bardia
Tomas G. Neilan
Sara R. Schoenfeld
Chin Hur
Michael Dougan
Source :: Journal of Clinical Oncology. 36:3060-3060
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 3060Background: Immune checkpoint inhibitors such as anti-CTLA4 and anti-PD1 antibodies represent a paradigm shift in the treatment of many advanced malignancies. However, immune related adverse ef...

Full Text Access

Tools